Financial statements are reported in CAD and shown here converted to USD at today's exchange rate.
ACB — Aurora Cannabis Inc.
$4.94
$-0.05 (-1.00%)
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Market Cap
$324.78M
Forward P/E
-44.9x
52-Week Range
N/A
ACB Price History
Revenue vs. Net Income
$225M
Revenue · FY2026
Annual. Net margin is shown under each year.
Free Cash Flow
-$25.3M
FCF · FY2026
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-10.2%
ROCE · FY2026
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
6.7x
Assets ÷ liabilities · FY2026
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
7.0%
CapEx · FY2026
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+3.4%
Dilution · FY2026
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
